Published in Hepatitis Weekly, June 3rd, 2002
Operating income in the first quarter was a record $65.8 million compared with $41.2 million, an increase of 60%.
Net income was a record $33.7 million compared with $21.0 million in the first quarter of 2001, an increase of 60%. Earnings per share for the first quarter were $0.40, compared with $0.26, an increase of 54%. Net income included a benefit of $3.5 million from the cumulative effect of change in accounting principle. The company is currently evaluating its remaining goodwill. First...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.